Key result
Inflammatory biomarkers are validated for assessing clinical status and prognosis in heart failure, though their diagnostic utility and the efficacy of anti-inflammatory therapies remain debated.
Population
Patients with heart failure
Design
Review
Authors
Loading...
May aid HF prognostic stratification; leaves open diagnostic utility and anti-inflammatory therapy efficacy.
This review highlights the prognostic value of inflammatory biomarkers in heart failure and suggests that standard guideline-directed medical therapies may exert some of their benefits through anti-inflammatory mechanisms.
Cialdella et al. (2011) conducted a review in Heart failure. Inflammatory biomarkers was evaluated. Inflammatory biomarkers are validated for assessing clinical status and prognosis in heart failure, though their diagnostic utility and the efficacy of anti-inflammatory therapies remain debated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: